|
MSMRD
|
Myeloma Stratification and Risk-Adapted Therapy with Reflex to Measurable/Minimal Residual Disease, Bone Marrow Mayo Clinic Laboratories in Rochester
|
|
MPO
|
Myeloperoxidase Antibodies, IgG, Serum Mayo Clinic Laboratories in Rochester
|
|
MPNR
|
Myeloproliferative Neoplasm, JAK2 V617F with Reflex to CALR and MPL, Varies Mayo Clinic Laboratories in Rochester
|
|
GNMY9
|
MYH9-Related Disorders, MYH9 Gene, Next-Generation Sequencing, Varies Mayo Clinic Laboratories in Rochester
|
|
MEF2B
|
Myocyte Enhancer Factor 2 (MEF2B) Immunostain, Technical Component Only Mayo Clinic Laboratories in Rochester
|
|
MYODT
|
MYOD1 Mutation Analysis, Next-Generation Sequencing, Tumor Mayo Clinic Laboratories in Rochester
|
|
MYGLS
|
Myoglobin, Serum Mayo Clinic Laboratories in Rochester
|
|
FMMPP
|
MyoMarker 3 Plus Profile Esoterix Endocrinology
|
|
FMYO3
|
MyoMarker 3 Profile Esoterix Endocrinology
|
|
MSAES
|
Myositis Specific Antibody Evaluation, Serum Mayo Clinic Laboratories in Rochester
|